Mycophenolate: Clinical Trials

18 trials of Mycophenolate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 terminated, 2 active not recruiting, 2 not yet recruiting. 7 Phase 4, 6 Phase 2, 2 Phase 1, 2 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 47Completed 4, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 26Completed 2, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 12Completed 2
Phase 32Terminated 1, Unknown 1
Not applicable1Active not recruiting 1

Follow Mycophenolate: new trials by email Literature Review of Mycophenolate trials Research Report on Mycophenolate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil - Psoriasis, Atopic Dermatitis
Phase 4Not yet recruitingUniversity of California, San Francisco102026-08-012026-06-03
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Methotrexate, Sulfasalazine, Hydroxychloroquine - Rheumatic Disease
Phase 2RecruitingNYU Langone Health802025-12-122026-07-09
BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)
BIVV020 (SAR445088), Intravenous immunoglobulin (IVIg), Rituximab or biosimilar - Transplant Rejection
Phase 2Active not recruitingSanofi482022-06-092026-08-21
Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid
Baricitinib 2 MG [Olumiant], Methotrexate, Azathioprine - Mucous Membrane Pemphigoid, Cicatrizing Conjunctivitis
Phase 2TerminatedWashington University School of Medicine22022-02-212023-11-07
Outcomes of Patients After Allo-HSCT With Decitabine and NAC
decitabine, Acetylcysteine, Semustine - Engraft Failure, Relapse
Phase 3UnknownThe First Affiliated Hospital of Soochow University1002021-07-012021-06-30
Comparison between2 Drugs in Lupus Nephritis
cyclo phosphamide, mycophenolate - Lupus Nephritis
Phase 4CompletedAl-Azhar University402021-04-052022-06-21
Immune Monitoring to Facilitate Belatacept Monotherapy
Allosure, Immunosuppression reduction, Trugraf - Kidney Transplant Rejection, Immunosuppression
Phase 4CompletedMassachusetts General Hospital172020-02-112023-12-04
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
Reduced immunosuppression, Tacrolimus, mycophenolate - Immunosuppression After Renal Transplantation
Phase 4UnknownKlemens Budde4002017-12-012017-08-09
European Transplant Registry of Senior Renal Transplant Recipients on Advagraf
Tacrolimus once daily (Advagraf) - Graft Failure, Death
Not yet recruitingKlemens Budde10002016-12-012016-08-12
Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility
Uterine Transplant - Absolute Uterine Infertility
Not applicableActive not recruitingBaylor Research Institute382015-11-112026-03-23
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
Fludarabine, Cyclophosphamide, Mesna - Leukemia, MDS
Phase 1CompletedRafic Farah, MD282015-02-112019-10-15
Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients
Belatacept, Tacrolimus, Mycophenolate - Implant or Graft; Rejection
Phase 4CompletedColumbia University572014-06-012021-02-10
Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients
sirolimus, tacrolimus, mycophenolate - Disorder Related to Renal Transplantation, Cytomegalovirus Infections
Phase 4CompletedAssociação Médico Espírita de Botucatu482014-01-012016-02-17
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging - Leukemia, Lymphoma
Phase 2CompletedM.D. Anderson Cancer Center202013-01-012020-05-05
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
Low Molecular Weight Sulfated Dextran, Heparin, Mycophenolate Mofetil - Diabetes Mellitus, Type I
Phase 2WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2008-07-012014-06-12
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Sirolimus, Azathioprine, Mycophenolate - Skin Cancer
Phase 4TerminatedCharite University, Berlin, Germany442007-01-012025-03-14
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis
mycophenolate mofetil, placebo - Systemic Lupus Erythematosus, Arthritis
Phase 1 / Phase 2CompletedOklahoma Medical Research Foundation272006-11-012020-10-09
Mycophenolate for Pulmonary Sarcoidosis
Mycophenolate - Pulmonary Sarcoidosis
Phase 3TerminatedMedical University of South Carolina202003-09-012018-06-18

Conditions studied

Leukemia (2)  ·  Lupus Erythematosus, Systemic (2)  ·  Lymphoma (2)  ·  Arthritis (1)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Psoriatic (1)  ·  Arthritis, Rheumatoid (1)  ·  Bone Diseases (1)  ·  Cytomegalovirus Infections (1)  ·  Death (1)  ·  Delayed Graft Function (1)  ·  Dermatitis, Atopic (1)  ·  Dermatomyositis (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Giant Cell Arteritis (1)

Sponsors

Klemens Budde (2)  ·  Al-Azhar University (1)  ·  Associação Médico Espírita de Botucatu (1)  ·  Baylor Research Institute (1)  ·  Charite University, Berlin, Germany (1)  ·  Columbia University (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  Medical University of South Carolina (1)  ·  NYU Langone Health (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Oklahoma Medical Research Foundation (1)  ·  Rafic Farah, MD (1)  ·  Sanofi (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

United States (11)  ·  Germany (2)  ·  Canada (1)  ·  Egypt (1)  ·  France (1)  ·  Italy (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Don C Rockey, MD (1)  ·  Hannah Gilligan, MD (1)  ·  Issa F. Khouri, MD,BS (1)  ·  Joan T. Merrill, M.D. (1)  ·  Jonathan Samuels, MD (1)  ·  Klemens Budde, MD (1)  ·  Lukas J Lehner, MD (1)  ·  Marc A Judson, MD (1)  ·  Mark A. Hardy, MD (1)  ·  Olle Korsgren, MD (1)  ·  Petra Reinke, Prof. Dr. (1)  ·  Rafic J Farah, MD (1)  ·  Raymond Cho, MD, PhD (1)  ·  Robert Clancy, PhD (1)  ·  Yue Han, Prof. (1)

Results publications

PMID 29364592, PMID 32150040, PMID 33416285, PMID 33481553, PMID 33716072, PMID 33878776, PMID 34713738, PMID 35332298, PMID 37606907, PMID 37994646, PMID 38631504, PMID 38636770, PMID 39145955, PMID 39166465

NIH funding

2014 (1), 2023 (1)